Feeds:
Posts
Comments

Archive for the ‘Award Nominations’ Category


The Nobel Prize in Chemistry 2020: Emmanuelle Charpentier & Jennifer A. Doudna

Reporters: Stephen J. Williams, Ph.D. and Aviva Lev-Ari, PhD, RN

 

UPDATED on 11/12/2020

Harvard’s Jack Szostak congratulates former advisee Jennifer Doudna

It was a toast from one Nobel laureate to another, sweetened by the pride of a mentor to a prized student.

When Jennifer Doudna Ph.D. ’89 was honored on Wednesday with the Nobel Prize in chemistry for her work on the CRISPR gene-editing technique, she became the second person to gain such an honor from the lab of Jack Szostak, a genetics professor at Harvard Medical School and Massachusetts General Hospital, and professor of chemistry and chemical biology at Harvard’s Faculty of Arts and Sciences.

Szostak, who won the Nobel Prize in physiology or medicine in 2009 for work on how telomere caps keep the body’s chromosomes from breaking down, advised Doudna’s doctoral work on RNA and on Wednesday raised a glass in honor of Doudna, now at the University of California, Berkeley. In a tweet, Szostak expressed his delight at seeing someone he once guided through her early scientific steps soar to science’s highest reaches:

Doudna received the prize together with Emmanuelle Charpentier, for their work discovering and developing CRISPR as a precise gene-editing tool. In just the eight years since the pair announced their discovery the use of the technique has rapidly spread to a host of fields, allowing researchers to alter the code of life and develop resistant crops, new medical therapies, and even anticipate curing inherited diseases.

 

UPDADTED on 11/2/2020

 

Announcement of the Nobel Prize in Chemistry 2020

Live webcast from the press conference where the Royal Swedish Academy of Sciences will announce the Nobel Prize in Chemistry 2020.

 

 

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to

Emmanuelle Charpentier
Max Planck Unit for the Science of Pathogens, Berlin, Germany

Jennifer A. Doudna
University of California, Berkeley, USA

“for the development of a method for genome editing”

Genetic scissors: a tool for rewriting the code of life

Emmanuelle Charpentier and Jennifer A. Doudna have discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors. Using these, researchers can change the DNA of animals, plants and microorganisms with extremely high precision. This technology has had a revolutionary impact on the life sciences, is contributing to new cancer therapies and may make the dream of curing inherited diseases come true.

Researchers need to modify genes in cells if they are to find out about life’s inner workings. This used to be time-consuming, difficult and sometimes impossible work. Using the CRISPR/Cas9 genetic scissors, it is now possible to change the code of life over the course of a few weeks.

“There is enormous power in this genetic tool, which affects us all. It has not only revolutionised basic science, but also resulted in innovative crops and will lead to ground-breaking new medical treatments,” says Claes Gustafsson, chair of the Nobel Committee for Chemistry.

As so often in science, the discovery of these genetic scissors was unexpected. During Emmanuelle Charpentier’s studies of Streptococcus pyogenes, one of the bacteria that cause the most harm to humanity, she discovered a previously unknown molecule, tracrRNA. Her work showed that tracrRNA is part of bacteria’s ancient immune system, CRISPR/Cas, that disarms viruses by cleaving their DNA.

Charpentier published her discovery in 2011. The same year, she initiated a collaboration with Jennifer Doudna, an experienced biochemist with vast knowledge of RNA. Together, they succeeded in recreating the bacteria’s genetic scissors in a test tube and simplifying the scissors’ molecular components so they were easier to use.

In an epoch-making experiment, they then reprogrammed the genetic scissors. In their natural form, the scissors recognise DNA from viruses, but Charpentier and Doudna proved that they could be controlled so that they can cut any DNA molecule at a predetermined site. Where the DNA is cut it is then easy to rewrite the code of life.

Since Charpentier and Doudna discovered the CRISPR/Cas9 genetic scissors in 2012 their use has exploded. This tool has contributed to many important discoveries in basic research, and plant researchers have been able to develop crops that withstand mould, pests and drought. In medicine, clinical trials of new cancer therapies are underway, and the dream of being able to cure inherited diseases is about to come true. These genetic scissors have taken the life sciences into a new epoch and, in many ways, are bringing the greatest benefit to humankind.

Illustrations

The illustrations are free to use for non-commercial purposes. Attribute ”© Johan Jarnestad/The Royal Swedish Academy of Sciences”

Illustration: Using the genetic scissors (pdf)
Illustration: Streptococcus’ natural immune system against viruses:CRISPR/Cas9 pdf)
Illustration: CRISPR/Cas9 genetic scissors (pdf)

Read more about this year’s prize

Popular information: Genetic scissors: a tool for rewriting the code of life (pdf)
Scientific Background: A tool for genome editing (pdf)

Emmanuelle Charpentier, born 1968 in Juvisy-sur-Orge, France. Ph.D. 1995 from Institut Pasteur, Paris, France. Director of the Max Planck Unit for the Science of Pathogens, Berlin, Germany.

Jennifer A. Doudna, born 1964 in Washington, D.C, USA. Ph.D. 1989 from Harvard Medical School, Boston, USA. Professor at the University of California, Berkeley, USA and Investigator, Howard Hughes Medical Institute.

SOURCE

https://www.nobelprize.org/prizes/chemistry/2020/press-release/

 

Nobel Prize in Chemistry awarded to scientists who discovered CRISPR gene editing tool for ‘rewriting the code of life’

(CNN)The Nobel Prize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing.

They discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors. Using these, researchers can change the DNA of animals, plants and micro-organisms with extremely high precision.
Before announcing the winners on Wednesday, Göran K. Hansson, secretary-general for the Royal Swedish Academy of Sciences, said that this year’s prize was about “rewriting the code of life.”
The American biochemist Jennifer A. Doudna (left) and French microbiologist Emmanuelle Charpentier, pictured together in 2016.
 
The CRISPR/Cas9 gene editing tools have revolutionized the molecular life sciences, brought new opportunities for plant breeding, are contributing to innovative cancer therapies and may make the dream of curing inherited diseases come true, according to a press release from the Nobel committee.
 
 
There have also been some ethical concerns around the CRISPR technology, however.
Charpentier, a French microbiologist, and Doudna, an American biochemist, are the first women to jointly win the Nobel Prize in Chemistry, and the sixth and seventh women to win the chemistry prize.
close dialog

 

Jennifer Doudna wins 2020 Nobel Prize in chemistry

 

First Day in a Nobel Life: Jennifer Doudna

12,365 views
Oct 7, 2020
 
Scenes from day that UC Berkeley Professor Jennifer Doudna won the Nobel Prize For the full story, visit: https://news.berkeley.edu/2020/10/07/… University of California, Berkeley, biochemist Jennifer Doudna today won the 2020 Nobel Prize in Chemistry, sharing it with colleague Emmanuelle Charpentier for the co-development of CRISPR-Cas9, a genome editing breakthrough that has revolutionized biomedicine. CRISPR-Cas9 allows scientists to rewrite DNA — the code of life — in any organism, including human cells, with unprecedented efficiency and precision. The groundbreaking power and versatility of CRISPR-Cas9 has opened up new and wide-ranging possibilities across biology, agriculture and medicine, including the treatment of thousands of intractable diseases. Doudna and Charpentier, director of the Max Planck Institute for Infection Biology, will share the 10 million Swedish krona (more than $1 million) prize. “This great honor recognizes the history of CRISPR and the collaborative story of harnessing it into a profoundly powerful engineering technology that gives new hope and possibility to our society,” said Doudna. “What started as a curiosity‐driven, fundamental discovery project has now become the breakthrough strategy used by countless researchers working to help improve the human condition. I encourage continued support of fundamental science as well as public discourse about the ethical uses and responsible regulation of CRISPR technology.” Video by Clare Major & Roxanne Makasdjian
SOURCE

 

Jennifer Doudna wins 2020 Nobel Prize in chemistry

 

Jennifer Doudna in the PBS Movie CRISPR

Our critically-acclaimed documentary HUMAN NATURE is now streaming on NETFLIX. #HumanNatureFilm. Find out more about the film on our website.

 

Other Articles on the Nobel Prize in this Open Access Journal Include:

2020 Nobel Prize for Physiology and Medicine for Hepatitis C Discovery goes to British scientist Michael Houghton and US researchers Harvey Alter and Charles Rice

CONTAGIOUS – About Viruses, Pandemics and Nobel Prizes at the Nobel Prize Museum, Stockholm, Sweden 

AACR Congratulates Dr. William G. Kaelin Jr., Sir Peter J. Ratcliffe, and Dr. Gregg L. Semenza on 2019 Nobel Prize in Physiology or Medicine

2018 Nobel Prize in Physiology or Medicine for contributions to Cancer Immunotherapy to James P. Allison, Ph.D., of the University of Texas, M.D. Anderson Cancer Center, Houston, Texas. Dr. Allison shares the prize with Tasuku Honjo, M.D., Ph.D., of Kyoto University Institute, Japan

2017 Nobel prize in chemistry given to Jacques Dubochet, Joachim Frank, and Richard Henderson  for developing cryo-electron microscopy

2016 Nobel Prize in Chemistry awarded for development of molecular machines, the world’s smallest mechanical devices, the winners: Jean-Pierre Sauvage, J. Fraser Stoddart and Bernard L. Feringa

Correspondence on Leadership in Genomics and other Gene Curations: Dr. Williams with Dr. Lev-Ari

Programming life: An interview with Jennifer Doudna by Michael Chui, a partner of the McKinsey Global Institute

Read Full Post »


Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

 

Prepared for publication in American Friends of the Hebrew University (AFHU), May 2018 Newsletter, Hebrew University’s HUJI Alumni Spotlight Section.

The profile was up on 5/3/2018 on AFHU website under the Alumni Spotlight at https://www.afhu.org/

Excerpts were Published in AFHU e-news on 5/11/2018.

https://us10.campaign-archive.com/?u=5c25136c60d4dfc4d3bb36eee&id=757c5c3aae&e=d09d2b8d72

https://www.afhu.org/2018/05/03/aviva-lev-ari/

Aviva Lev-Ari, PhD, RN – February 2018

  • On 3/31/2018 was nominated for 2018 Yidan Foundation Prize.

About the Yidan Prize

Founded in 2016 by Dr Charles CHEN Yidan, the Yidan Prize has a mission to create a better world through education. Through a series of initiatives – research, events and multimedia content – alongside the annual award, the prize serves to establish a platform that allows the global community to engage in conversation around education and to play a role in education philanthropy.

 On 9/27/2018 The Yidan Prize Announces Laureates 2018: 

The Yidan Prize’s laureates this year are Northwestern University’s Professor Larry HEDGES and eDX’s founder and CEO, Professor Anant AGARWAL.

Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

 

Please read about my Five Passions

  • Cherry Blossom

When the cherry blossoms bloomed They brought beauty to my heart. Tatsu-jo¹

 

  • Harp Music

The Role of the Harp and of Music in Medical Recovery

 

  • Music and Curation in Music

Power of Analogy: Curation in Music, Music Critique as a Curation and Curation of Medical Research Findings – A Comparison

 

  • Bob Dylan “for having created new poetic expressions within the great American song tradition”.

Nobel Lecture, 6/5/2017 and Acceptance Speech – Bob Dylan – 2016 Nobel Prize Gala — Bob Dylan Awarded Nobel Prize in Literature, Scientists cited his verses in Scientific Article Titles

 

  • 3D Printing in Fashion Design

3D Printing in Fashion Design – 2016 Exhibit at Museum of Fine Arts, Boston, #techstyle March 6, 2016 – July 10, 2016 Henry and Lois Foster Gallery (Gallery 158)

https://pharmaceuticalintelligence.com/2016/01/24/neri-oxman-design-at-the-intersection-of-technology-and-biology/

 

Autobiographical expressions made in the following creative writings:

 

Education

  • Elementary School Giv’at Nesher, Israel 1959-1964 (Top 5)

Recipient of National Award in Geography of Israel, 1963

  • Huggim High School, Mount Carmel, Haifa, Israel, 1965-1968 (Top 5): Economics and Social Sciences concentration
  • HUJI, BA, 1973 (with Distinction) Geography and History;
  • HUJI, MA, 1976 (Summa Cum Laude) Urban Planning.
  • University of California, Berkeley, PhD, 1983. Economic Geography and Industrial Organization Economics, Department of Geography.
  • Northeastern University, Biological Sciences, 2005, Nursing, 2007.

My career had several phases:

  • Phase 1: Research, 1973 – 1983
  • Phase 2: Corporate Applied Research in the US, 1985 – 2005
  • Phase 3: Career Reinvention in Health Care, 2005 – 2012
  • Phase 4: Electronic Scientific Publishing, 4/2012 to Present

 

Phase 1: Research, 1973 – 1983

In Israel, Research Track

  • Masters level in the Urban Studies Department, HUJI, 1973-1976; thesis advisor: Prof. Amiram Gonen
  • Work and Welfare Research Institute (WWRI), HUJI, 1975-1976, research assistant to Prof. Shalom Reichman, WWRI director: Prof. Rivka W. Bar-Yosef, and
  • Technion, Transportation Research Center (TRC), 1977-1978, research associate and team leader, in Dr. Moshe Becker’s group, Road Safety Center (RSC).

My education at HUJI was crucial in attaining a Research Associate position at the Technion, 1977-1978. The years of research for my Masters at HUJI and the two years at the Technion contributed to my professional motivation and confidence to pursue a PhD at University of California, Berkeley, 9/1978 – 12/1983.

I arrived at my first research position at the Technion following my Masters at HUJI. I was extremely well prepared for the challenge. I was well versed in research methodologies and mastered advanced skills in scientific and technical oral and written communication. These most important skills served me very well three years later when I started my doctorate at University of California, Berkeley.

My professors at HUJI wrote recommendation letters for me which where critical for admission to the PhD program. I remained in contact with them till some passed away, Prof. Louis Guttman in 1989 and Prof. Shalom Reichman in 1994. I am in contact to this day with Prof. Ruth Kark, Dr. Shlomit Levy, and Dr. Sara Hershkovits. I was one of their very able students. On my annual visit in Israel, I meet with all the three.

 

In California, Doctoral Program at Berkeley, Industrial Organization Economics, Economic Geography, 9/1978 – 12/1983. Advisor: Prof. Allan Pred

Comments I made on 3/8/2018 to Nathan F. SAYRE, department chairman:

“The death of Allan Pred, was a colossal loss to humanity and to human geography. Like Albert Einstein’s death was an irrecoverable loss to the physics community and to the universe he researched and modeled!!!”

My own dissertation was creative and led to my first job in the US, after graduation, director level at SRI, International in Menlo Park, CA 

Without the aura of a Berkeley PhD – I could not have been able to carry the torch that guided me to where I am in 2018, an owner of a knowledge-based venture with significant intellectual property, planning to transfer ownership in 2019/20. 

I have expressed my feelings and impressions of my years at Berkeley in the following two articles: 

  • Recollections: Part 1 – My days at Berkeley, 9/1978 – 12/1983 –About my doctoral advisor, Allan Pred, other Professors and other Peers

https://pharmaceuticalintelligence.com/2018/03/15/recollections-my-days-at-berkeley-9-1978-12-1983-about-my-doctoral-advisor-allan-pred-other-professors-and-other-peer/

  • Recollections: Part 2 – “While Rolling” is preceded by “While Enrolling” Autobiographical Alumna Recollections of Berkeley – Aviva Lev-Ari, PhD’83

https://pharmaceuticalintelligence.com/2018/05/24/recollections-part-2-while-rolling-is-preceded-by-while-enrolling-autobiographical-alumna-recollections-of-berkeley-aviva-lev-ari-phd83/

 

Phase 2: Corporate Applied Research in the US, 1985 – 2005

Twenty years of top-tier management consulting and as a corporate executive. In the corporate world, I worked for Fortune 50 companies, using the principles of statistical modeling, economic geography, and of industrial organization economics, every day.

See

LinkedIn Profile

Accomplishments

Data Science is the Greatest Science. It is the Greatest Science for Women, as Well

Pioneering implementations of Analytics to Business decision making: Contributions to Domain knowledge conceptualization, Research design, Methodology development, Data modeling and Statistical data analysis: Aviva Lev-Ari, UCB, PhD’83; HUJI MA’76

 

Phase 3: Career Reinvention in Health Care, 2005 – 2012

Education

  • Northeastern University, Biological Sciences, 2005
  • Northeastern University, Nursing, 2007, National Nursing Board, 1/2008

Work experience in Health Care

https://pharmaceuticalintelligence.com/founder/scientific-and-medical-affairs-chronological-cv/

 

  • Delivery of Care in MA – Post Acute Nursing Management positions, 2008 – 2012

HealthCare Delivery – Long Term Post Acute Care Nursing Management CV

 

  • Cardiovascular pharmacology-therapy research, development of a combination drug therapy, 2006-2007, Northeastern University, with Prof. Paul Aburjaily, PharmD

https://pharmaceuticalintelligence.com/2012/07/16/bystolics-generic-nebivolol-positive-effect-on-circulating-endothilial-progrnetor-cells-endogenous-augmentation/

 

  • Conceptual development with a team of scientists on Drug Discovery & Drug Delivery, 2015-2016, LPBI Group, with Dr. Raphael Nir, SBH Sciences, CEO.

https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/

 

Phase 4: Electronic Scientific Publishing, 4/2012 to Present

Twitter Profile

 

  • 2012 – Present, Editor-in-Chief, Open Access Online Scientific Journal

https://pharmaceuticalintelligence.com/about/

Site statistics on 5/26/2018:

  1. 1,435,270 e-Readers,
  2. 2,340 subscribers,
  3. 5,318 Scientific Articles,
  4. ~8000 comments by scientists

 

  • Editor-in-Chief of 13 Volumes of a 16-Volume LPBI’s BioMed e-Series, published, 2013 – 2017, available on Amazon.com shelves in Medicine and Life Sciences. Three additional volumes will be published in 2018/9:

Aviva’s Page on Amazon.com

https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Ddigital-text&field-keywords=Aviva+Lev-Ari&rh=n%3A133140011%2Ck%3AAviva+Lev-Ari

 

  • 557 Co-Curations, single author curations and scientific reports in 13 Volumes of LPBI’s BioMed e-Series by Aviva Lev-Ari, PhD, RN

https://www.linkedin.com/pulse/557-co-curations-single-author-curation-scientific-13-aviva/

 

  • Press coverage of BioMed and BioTech Conferences in Real Time, attendance on Press Pass

https://pharmaceuticalintelligence.com/press-coverage/

 

 

Additional Sources for Chronological CV

https://pharmaceuticalintelligence.com/founder/

 

 

 

Read Full Post »


International Award for Human Genome Project

Reporter and Curator: Dr. Sudipta Saha, Ph.D.

 

The Thai royal family awarded its annual prizes in Bangkok, Thailand, in late January 2018 in recognition of advances in public health and medicine – through the Prince Mahidol Award Foundation under the Royal Patronage. This foundation was established in 1992 to honor the late Prince Mahidol of Songkla, the Royal Father of His Majesty King Bhumibol Adulyadej of Thailand and the Royal Grandfather of the present King. Prince Mahidol is celebrated worldwide as the father of modern medicine and public health in Thailand.

 

The Human Genome Project has been awarded the 2017 Prince Mahidol Award for revolutionary advances in the field of medicine. The Human Genome Project was completed in 2003. It was an international, collaborative research program aimed at the complete mapping and sequencing of the human genome. Its final goal was to provide researchers with fundamental information about the human genome and powerful tools for understanding the genetic factors in human disease, paving the way for new strategies for disease diagnosis, treatment and prevention.

 

The resulting human genome sequence has provided a foundation on which researchers and clinicians now tackle increasingly complex problems, transforming the study of human biology and disease. Particularly it is satisfying that it has given the researchers the ability to begin using genomics to improve approaches for diagnosing and treating human disease thereby beginning the era of genomic medicine.

 

National Human Genome Research Institute (NHGRI) is devoted to advancing health through genome research. The institute led National Institutes of Health’s (NIH’s) contribution to the Human Genome Project, which was successfully completed in 2003 ahead of schedule and under budget. NIH, is USA’s national medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases.

 

Building on the foundation laid by the sequencing of the human genome, NHGRI’s work now encompasses a broad range of research aimed at expanding understanding of human biology and improving human health. In addition, a critical part of NHGRI’s mission continues to be the study of the ethical, legal and social implications of genome research.

 

References:

 

https://www.nih.gov/news-events/news-releases/human-genome-project-awarded-thai-2017-prince-mahidol-award-field-medicine

 

http://www.mfa.go.th/main/en/news3/6886/83875-Announcement-of-the-Prince-Mahidol-Laureates-2017.html

 

http://www.thaiembassy.org/london/en/news/7519/83884-Announcement-of-the-Prince-Mahidol-Laureates-2017.html

 

http://englishnews.thaipbs.or.th/us-human-genome-project-influenza-researchers-win-prince-mahidol-award-2017/

 

http://genomesequencing.com/the-human-genome-project-is-awarded-the-thai-2017-prince-mahidol-award-for-the-field-of-medicine-national-institutes-of-health-press-release/

 

Read Full Post »


Nominations for 2016 National Academies Communication Awards For Excellence in Reporting and Communicating Sciences, Engineering, and Medicine, Keck Futures Initiative

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

 

Submission for Category: Online

From: <form_engine@fs22.formsite.com> on behalf of “commawards@nas.edu” <form_engine@fs22.formsite.com>

Reply-To: <commawards@nas.edu>

Date: Wednesday, January 27, 2016 at 3:25 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: 2016 Communication Awards Nomination Form Result #9076095

 

The National Academies of Sciences, Engineering, and Medicine



 

2016 Communication Awards 
For Excellence in Reporting and Communicating

Sciences, Engineering, and Medicine

 

Nomination Confirmation 

 

Thank you for submitting a nomination for the 2016 National Academies Communication Awards.

 

Please select the category of your nomination: * Online
Online Entry Title: * Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, Milestones
Online Publisher(s): * Leaders in Pharmaceutical Business Intelligence, BioMed e-Series https://pharmaceuticalintelligence.com/biomed-e-books/, Amazon.com
Online Publish Date: * 2015-08-11
Online Entry Summary (Please limit to 100 words): * BioMed e-Series published in 2015 e-Books to popularize the Scientific findings of the frontier in Medicine and Life Sciences focusing on the top two Public HealthCare hazards: Cardiovascular Diseases and Cancer. The e-Series consists of medical interpretations of the most challenging causes of mortality and morbidities in Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, the Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, the Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics. Precision Medicine as in Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases.

ANNOUNCEMENT

Success – Thank You! Reference #: 9076095: The National Academies 2016 Communication Awards Nomination

I AM PROUD TO CONGRATULATE

  • Larry H Bernstein, MD, FCAP
  • Stephen J Williams, PhD
  • Tilda Barliya, PhD
  • Dror Nir, PhD

 

They constitute the TEAM that I nominated for 

The National Academies 2016 Communication Awards, Keck Futures Initiative – Nomination 

  • Category: Online 
  • Subject for Nomination: BioMed e-Series published in 2015 by Leaders in Pharmaceutical Business Intelligence on Amazon.com

 

BioMed e-Series

https://pharmaceuticalintelligence.com/biomed-e-books/

  • Cancer Biology & Genomics for Disease Diagnosis,
  • Genomics Orientations for Personalized Medicine,
  • Metabolic Genomics and Pharmaceutics,
  • Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics,
  • Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics,
  • Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases

100 words

BioMed e-Series published in 2015 e-Books to popularize the Scientific findings of the frontier in Medicine and Life Sciences focusing on the top two Public HealthCare hazards: Cardiovascular Diseases and Cancer. The e-Series consists of medical interpretations of the most challenging causes of mortality and morbidities in Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, the Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, the Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics. Precision Medicine as

https://fs22.formsite.com/res/showSuccessPage?EParam=m%2FOmK8apOTBRmouoTFrqiVATUbkBsVmGEQn3K0X14DG3VhR5CvnKsC1mzhLD6ne%2BXKN%2Fe20J%2FjE%3D

https://fs22.formsite.com/naseo-ca/2016_com_award_nom/index.html

 

Effective 1/27/2016

LPBI’s BioMed e-Series  was Submitted on 1/27/2016 for The National Academies of Sciences, Engineering, and Medicine



2016 Communication Awards 
For Excellence in Reporting and Communicating

Sciences, Engineering, and Medicine

 

The Keck Futures Initiative – a program of the National Academies of Sciences, Engineering, and Medicine, with the support of the W.M. Keck Foundation – will award four $20,000 prizes in 2016 to individuals or teams (up to four individuals associated with the creation of the work being nominated) who have developed creative, original works that address issues and advances in science, engineering and/or medicine for the general public. Nominations are accepted in four categories: Book; Film/Radio/TV; Magazine/Newspaper; and Online. The winners will be honored in the Fall 2016 and are expected to attend in person.

http://keckfutures.org/awards/nominate.html

Submission for Category: Magazine/Newspaper

From: <form_engine@fs22.formsite.com> on behalf of “commawards@nas.edu” <form_engine@fs22.formsite.com>

Reply-To: <commawards@nas.edu>

Date: Monday, February 1, 2016 at 11:37 AM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: 2016 Communication Awards Nomination Form Result #9101075

 

The National Academies of Sciences, Engineering, and Medicine



 

2016 Communication Awards 
For Excellence in Reporting and Communicating

Science, Engineering, and Medicine

 

Nomination Confirmation 

 

 

Thank you for submitting a nomination for the 2016 National Academies Communication Awards.

 

Please select the category of your nomination: * Magazine/Newspaper
Publisher(s): * Leaders in Pharmaceutical Business Intelligence – http://pharmaceuticalintelligence.com
Magazine/Newspaper Entry Summary (Please limit to 100 words): * In February 2012, a new venture was launched Doing Business As (DBA) Leaders in Pharmaceutical Business Intelligence. Founder, Pharmaceutical Business Intelligence Services is Aviva Lev-Ari, PhD, RN.

 

An online scientific EXCHANGE — an Open Access Online Scientific Journal for curation and reporting on frontiers in Biomedical, Genomics, Biological Sciences, Healthcare Economics, Pharmacology, Pharmaceutical & Medicine. The website, http://pharmaceuticalintelligence.com a scientific, medical and business multi expert authoring environment in LIFE SCIENCES, PHARMACEUTICAL, HEALTHCARE & MEDICINE INDUSTRIES.

 

1,879 are following our Journal, 868,702 views, 7,175 scientific comments 4,068 Scientific Articles, 472 Categories of Research, 8,267 Tags — ALL that is BioTech !!!!!!!!

Success – Thank You! Reference #: 9101075: Category Magazine/Newspaper -The National Academies 2016 Communication Awards Nomination

I AM HAPPY YO SHARE WITH YOU THE NOMINATION OF OUR OPEN ACCESS ONLINE SCIENTIFIC JOURNAL 

http://pharmaceuticalintelligence.com

 

For The National Academies 2016 Communication Awards, Keck Futures Initiative – Nomination for

Excellence in Reporting and Communicating Science, Medicine and Engineering

 

  • Category: Magazine/Newspaper
  • Subject for Nomination: Journal published in 2015 by Leaders in Pharmaceutical Business Intelligence 

 

http://pharmaceuticalintelligence.com

100 words

In February 2012, a new venture was launched Doing Business As (DBA) Leaders in Pharmaceutical Business Intelligence. Founder, Pharmaceutical Business Intelligence Services is Aviva Lev-Ari, PhD, RN.

An online scientific EXCHANGE — an Open Access Online Scientific Journal for curation and reporting on frontiers in Biomedical, Genomics, Biological Sciences, Healthcare Economics, Pharmacology, Pharmaceutical & Medicine. The website,  http://pharmaceuticalintelligence.com a scientific, medical and business multi expert authoring environment in LIFE SCIENCES, PHARMACEUTICAL, HEALTHCARE & MEDICINE INDUSTRIES.

1,879 are following our Journal, 868,702 views, 7,175 scientific comments 4,068 Scientific Articles, 472 Categories of Research, 8,267 Tags — ALL that is BioTech !!!!!!!!

https://fs22.formsite.com/res/showSuccessPage?EParam=m%2FOmK8apOTBRmouoTFrqiVATUbkBsVmGEQn3K0X14DG3VhR5CvnKsC1mzhLD6ne%2BXKN%2Fe20J%2FjE%3D

https://fs22.formsite.com/naseo-ca/2016_com_award_nom/index.html

 

ANNOUNCEMENT

Effective 2/1/2016

LPBI’s http://pharmaceuticalintelligence.com was Submitted on 2/1/2016 to

2016 Communication Award – Excellence in Reporting and Communicating

Science, Medicine and Engineering

The Keck Futures Initiative – a program of the National Academies of Sciences, Engineering, and Medicine, with the support of the W.M. Keck Foundation – will award four $20,000 prizes in 2016 to individuals or teams (up to four individuals associated with the creation of the work being nominated) who have developed creative, original works that address issues and advances in science, engineering and/or medicine for the general public. Nominations are accepted in four categories: Book; Film/Radio/TV; Magazine/Newspaper; and Online. The winners will be honored in the Fall 2016 and are expected to attend in person.

http://keckfutures.org/awards/nominate.html

 

Submission for Category: Book

Nomination of e-Book, Series A: Cardiovascular Diseases, Volume 2, Cases in Development of Scientific Curation Methodology

2016 Communication Awards Nomination Form Result #9143807

The National Academies of Sciences, Engineering, and Medicine

2016 Communication Awards for Excellence in Reporting and Communicating Science, Medicine and Engineering


Nomination Confirmation 

 

Thank you for submitting a nomination for the 2016 National Academies Communication Awards. Below please find the supporting materials necessary for your nomination category, as well as the address to which they should be sent.

Please select the category of your nomination: *

Book

Book Title: *

Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation

Publisher(s): *

Amazon Kindle Direct

Publication Date: (Please select one): *

November 2015

Book Entry Summary (Please limit to 100 words): *

The explosion of scientific information has created difficulties tying together disparate discoveries, ideas, and potential applications. Pharmaceutical Business Intelligence is developing an innovative methodology for Global access to Biomedical knowledge rather than traditional search. To attain this complex goal they disseminate ORIGINAL Research via Content Curation by experts using critical thinking process & interpretation over open access networks, offering better organization and visibility of critical information useful for innovations in academic, clinical, and industrial research. Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation at http://www.amazon.com/dp/B018Q5MCN8 is nominated as an example of this methodology.

Are you nominating an individual or team (up to four individuals)? *

Team

Is this a self- or third-party nomination? *

Third-Party Nomination: I am nominating someone other than myself.

First Name *

Larry H

Last Name *

Bernstein, MD, FCAP

Title *

Chief Scientific Officer

Organization *

Leaders in Pharmaceutical Business Intelligence

Street Address

54 FIRETHORN LANE

City

NORTHAMPTON

State

MA

Postal Code

01060

Country

USA

E-Mail Address *

larry.bernstein@gmail.com

Phone Number *

4137278523

URL

http://pharmaceuticalintelligence.com

First Name

AVIVA

Last Name

Lev-Ari, PhD, RN

Organization

Leaders in Pharmaceutical Business Intelligence

E-Mail Address

avivalev-ari@alum.berkeley.edu

First Name

Justin D.

Last Name

Pearlman, MD, PhD, FACC

Organization

Leaders in Pharmaceutical Business Intelligence

E-Mail Address

jdmdphd@gmail.com

First Name *

Stephen J.

Last Name *

Williams, PhD

Title *

Editor

Organization *

Leaders in Pharmaceutical Business Intelligence

Street Address

7373 Ridge Avenue

Apt/Suite/Office

116

City

Philadelphia

State

PA

Postal Code

19128

Country

USA

E-Mail Address *

sjwilliamspa@comcast.net

Phone Number *

2154870259

URL

http://pharmaceuticalintelligence.com

How did you hear about this award? (Please check all that apply): *

  • Colleague/Word of Mouth
  • Email Announcement
  • Science 2.0
  • Science Online

Read Full Post »


The Keck Futures Initiative – a Program of the National Academies of Sciences, Engineering, and Medicine – Submission of http://pharmaceuticalintelligence.com – Nomination Form Result #9101075 – 2016 Communication Award – Excellence in Reporting in Science, Medicine and Engineering

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

LPBI’s http://pharmaceuticalintelligence.com was Submitted on 2/1/2016 to

2016 Communication Award – Excellence in Reporting in Science, Medicine and Engineering

2016 Communication Awards Nomination Form Result #9101075

The Keck Futures Initiative – a program of the National Academies of Sciences, Engineering, and Medicine, with the support of the W.M. Keck Foundation – will award four $20,000 prizes in 2016 to individuals or teams (up to four individuals associated with the creation of the work being nominated) who have developed creative, original works that address issues and advances in science, engineering and/or medicine for the general public. Nominations are accepted in four categories: Book; Film/Radio/TV; Magazine/Newspaper; and Online. The winners will be honored in the Fall 2016 and are expected to attend in person.

http://keckfutures.org/awards/nominate.html

Please select the category of your nomination: *

Magazine/Newspaper

Publisher(s): *

Leaders in Pharmaceutical Business Intelligence – http://pharmaceuticalintelligence.com

Magazine/Newspaper Entry Summary (Please limit to 100 words): *

In February 2012, a new venture was launched Doing Business As (DBA) Leaders in Pharmaceutical Business Intelligence. Founder, Pharmaceutical Business Intelligence Services is Aviva Lev-Ari, PhD, RN.

An online scientific EXCHANGE — an Open Access Online Scientific Journal for curation and reporting on frontiers in Biomedical, Genomics, Biological Sciences, Healthcare Economics, Pharmacology, Pharmaceutical & Medicine. The website, http://pharmaceuticalintelligence.com a scientific, medical and business multi expert authoring environment in LIFE SCIENCES, PHARMACEUTICAL, HEALTHCARE & MEDICINE INDUSTRIES.

1,879 are following our Journal, 868,702 views, 7,175 scientific comments 4,068 Scientific Articles, 472 Categories of Research, 8,267 Tags — ALL that is BioTech !!!!!!!!

Title: *

Cancer Signaling Pathways and Tumor Progression: Images of Biological Processes in the Voice of a Pathologist Cancer Expert

Month of Publication: *

June

Day of Publication:

09

Year of Publication: *

2015

Would you like to submit a link or upload a PDF for article one? *

Yes

If yes, select preferred format for article one: *

Link

Submit a link for article one *

https://pharmaceuticalintelligence.com/2015/06/09/cancer-signaling-pathways-and-tumor-progression-images-of-biological-processes-in-the-voice-of-a-pathologist-cancer-expert/

Title:

Diabetes is caused by Leaky Calcium Channels in Pancreatic Beta Cells – research @Columbia University Medical Center: The Role of RyR2 in Regulation o

Month of Publication:

April

Day of Publication:

14

Year of Publication:

2015

Would you like to submit a link or upload a PDF for article two?

Yes

If yes, select preferred format for article two:

Link

Submit a link for article two

https://pharmaceuticalintelligence.com/2015/04/14/diabetes-is-caused-by-leaky-calcium-channels-in-pancreatic-beta-cells-research-columbia-university-medical-center-the-role-of-ryr2-in-regulation-of-insulin-release-and-glucose-homeostasis/

Title:

65 Nobel Laureates meet 650 young scientists covering the fields of physiology and medicine, physics, and chemistry, 28 June – 3 July, 2015, Lindau &

Month of Publication:

July

Day of Publication:

13

Year of Publication:

2015

Would you like to submit a link or upload a PDF for article three?

Yes

If yes, select preferred format for article three:

Link

Submit a link for article three

https://pharmaceuticalintelligence.com/2015/07/13/65-nobel-laureates-meet-650-young-scientists-covering-the-fields-of-physiology-and-medicine-physics-and-chemistry-28-june-3-july-2015-lindau-mainau-island-germany/

Title:

Tweets by @pharma_BI and by @AVIVA1950: Real Time Coverage and eProceedings of The 11th Annual Personalized Medicine Conference, November 18-19, 2015,

Month of Publication:

November

Day of Publication:

23

Year of Publication:

2015

Would you like to submit a link or upload a PDF for article four?

Yes

If yes, select preferred format for article four:

Link

Submit a link for article four

https://pharmaceuticalintelligence.com/2015/11/23/tweets-by-pharma_bi-and-by-aviva1950-real-time-coverage-and-eproceedings-of-the-11th-annual-personalized-medicine-conference-november-18-19-2015-harvard-medical-school/

How do you prefer to release copyright to NAKFI? *

By checking this box you are allowing NAKFI to copy your submission materials.

Are you nominating an individual or team (up to four individuals)? *

Individual

Is this a self- or third-party nomination? *

Self Nomination: I am nominating myself.

First Name *

Aviva

Last Name *

Lev-Ari, PhD, RN

Title *

Founder

Organization *

Leaders in Pharmaceutical Business Intelligence

Street Address

83 Mandalay Road

City

Newton

State

Massa

Postal Code

02459

Country

United States

E-Mail Address *

avivalev-ari@alum.berkeley.edu

Phone Number *

6172444024

Mobile Phone

6177750451

URL

http://pharmaceuticalintelligence.com

How did you hear about this award? (Please check all that apply): *

Other (Florence George Graves Founding Director The Schuster Institute for Investigative Journalism & The Justice Brandeis Law Project Brandeis University )

Review Action *

Please take a moment to review your nomination information being submitted. Once you click the “Submit” button your nomination will be submitted. Thank you and best of luck!

 

2016 Communication Awards Nomination Form Result #9143807

The National Academies of Sciences, Engineering, and Medicine

2016 Communication Awards
Nomination Confirmation 

Book
Book Title: * Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation
Publisher(s): * Amazon Kindle Direct
Publication Date: (Please select one): * November 2015
Book Entry Summary (Please limit to 100 words): * The explosion of scientific information has created difficulties tying together disparate discoveries, ideas, and potential applications. Pharmaceutical Business Intelligence is developing an innovative methodology for Global access to Biomedical knowledge rather than traditional search. To attain this complex goal they disseminate ORIGINAL Research via Content Curation by experts using critical thinking process & interpretation over open access networks, offering better organization and visibility of critical information useful for innovations in academic, clinical, and industrial research. Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation at http://www.amazon.com/dp/B018Q5MCN8 is nominated as an example of this methodology.
Are you nominating an individual or team (up to four individuals)? * Team
Is this a self- or third-party nomination? * Third-Party Nomination: I am nominating someone other than myself.
First Name * Larry H
Last Name * Bernstein, MD, FCAP
Title * Chief Scientific Officer
Organization * Leaders in Pharmaceutical Business Intelligence
Street Address 54 FIRETHORN LANE
City NORTHAMPTON
State MA
Postal Code 01060
Country USA
E-Mail Address* larry.bernstein@gmail.com
Phone Number* 4137278523
URL http://pharmaceuticalintelligence.com
First Name AVIVA
Last Name Lev-Ari, PhD, RN
Organization Leaders in Pharmaceutical Business Intelligence
E-Mail Address avivalev-ari@alum.berkeley.edu
First Name Justin D.
Last Name Pearlman, MD, PhD, FACC
Organization Leaders in Pharmaceutical Business Intelligence
E-Mail Address jdmdphd@gmail.com
First Name * Stephen J.
Last Name * Williams, PhD
Title * Editor
Organization * Leaders in Pharmaceutical Business Intelligence
Street Address 7373 Ridge Avenue
Apt/Suite/Office 116
City Philadelphia
State PA
Postal Code 19128
Country USA
E-Mail Address* sjwilliamspa@comcast.net
Phone Number* 2154870259
URL http://pharmaceuticalintelligence.com

Read Full Post »